Vulvodynia incidence and remission rates among adult women - A 2-year follow-up study

被引:61
作者
Reed, Barbara D. [1 ]
Haener, Hope K.
Sen, Ananda
Gorenflo, Daniel W.
机构
[1] Univ Michigan, Dept Family Med, Sch Med, Ann Arbor, MI 48104 USA
关键词
D O I
10.1097/AOG.0b013e318180965b
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To estimate the incidence and remission rates of vulvodynia over a 2-year period. METHODS: A 2-year follow-up survey was sent to the University of Michigan Women's Health Registry members who had participated in a previously reported, validated survey. Changes in clinical status, incidence, and remission rates for vulvodynia were estimated, as were factors associated with new onset or remission of symptoms, using univariable and multivariable analyses. RESULTS: Of 1,037 women enrolled in the initial study, 744 women (71.7%) completed an online or written follow-up survey between September 2006 and March 2007. Of the 372 asymptomatic women controls at initial enrollment, 13 (3.5%, 95% confidence interval 1.6-5.4%) had developed vulvodynia during the 2-year follow-up period; nine (2.2%) of these had ongoing symptoms. Of 45 women with vulvodynia at initial enrollment, 10 (22.2%, 95% confidence interval 10.1-34.4%) indicated their symptoms had resolved. Factors at enrollment that were associated with incidence of vulvodynia were younger age and history of pain after intercourse. Remission was more common in women who did not have pain after intercourse and in those who reported less severe pain at enrollment. CONCLUSION: Based on 2-year follow-up, each year approximately one in 50 women develop symptoms of vulvodynia, and one in 10 women with vulvodynia report remission of symptoms.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 15 条
[1]  
Bachmann GA, 2006, J REPROD MED, V51, P447
[2]  
BAZIN S, 1994, OBSTET GYNECOL, V83, P47
[3]  
Bohm-Starke N, 2004, J REPROD MED, V49, P888
[4]   Use of oral contraceptive pills and vulvar vestibulitis: A case-control study [J].
Bouchard, C ;
Brisson, J ;
Fortier, M ;
Morin, C ;
Blanchette, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (03) :254-261
[5]   Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis [J].
Foster, DC ;
Hasday, JD .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (02) :291-296
[6]   VULVAR VESTIBULITIS - PREVALENCE AND HISTORIC FEATURES IN A GENERAL GYNECOLOGIC PRACTICE POPULATION [J].
GOETSCH, MF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (06) :1609-1616
[7]  
Haefner Hope K, 2005, J Low Genit Tract Dis, V9, P40, DOI 10.1097/00128360-200501000-00009
[8]  
Harlow Bernard L, 2003, J Am Med Womens Assoc (1972), V58, P82
[9]   Prevalence and predictors of chronic lower genital tract discomfort [J].
Harlow, BL ;
Wise, LA ;
Stewart, EG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (03) :545-550
[10]   Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis [J].
Jeremias, J ;
Ledger, WJ ;
Witkin, SS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (02) :283-285